Clinical Trial Update: Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study

View source ↗

Summary

Pilot study evaluating mycophenolate mofetil (Myfortic) for corticosteroid-refractory autoimmune uveitis; the current status of the trial is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Uveitis
• Uveitis

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Genovate Biotechnology Co., Ltd., | Conditions: Uveitis | Status: UNKNOWN